Haurwitz Rachel E.
SEC insider (Form 3/4/5 filer). CIK 0001670579. President and CEO at Caribou Biosciences, Inc. (CRBU). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 20, 2026. Located in BERKELEY, CA.
Companies Haurwitz Rachel E. has filed insider reports for
- Caribou Biosciences, Inc. (CRBU): Director, Officer, President and CEO
Haurwitz Rachel E.
CIK: 0001670579
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRBU
Caribou Biosciences, Inc.
DirectorOfficer